跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 74,325 条关于
“HSD-1 inhibitor”
全部
74,325
临床试验
43,982
药物
11,090
机构
1,425
资讯
17,828
11个月前
Sparrow Pharmaceuticals Secures $95 Million Series B to Advance Novel Diabetes Treatment Targeting Elevated Cortisol
去年
Clofutriben Granted FDA Orphan Drug Designation for Endogenous Cushing Syndrome
去年
Sparrow Pharmaceuticals' Clofutriben Completes Phase 2 Trial and Receives FDA Orphan Drug Designation for Cushing's Syndrome
8个月前
Sparrow Pharmaceuticals Initiates Phase 2b Trial of Clofutriben for Difficult-to-Control Type 2 Diabetes
去年
FDA Approves Osilodrostat for Second-Line Cushing Syndrome Treatment as Pipeline Advances
12个月前
FDA Approves First Subcutaneous PD-1 Inhibitor as MSD Launches Keytruda QLEX
2年前
Zynyz Plus Chemotherapy Shows Promise in Advanced Anal Cancer
去年
FDA's PD-1 Inhibitor Label Restrictions Spark Legal and Market Access Concerns
去年
PD-1 Inhibitor Label Restrictions May Impede Gastric Cancer R&D
10个月前
Chinese Researchers Discover Nicotinamide's Cardioprotective Effect Against PD-1 Inhibitor Toxicity
第 1 页,共 1783 页
上一页
下一页